Burning mouth syndrome responsive to pramipexol

被引：0
作者：
J. Stuginski-Barbosa
G. G. R. Rodrigues
M. E. Bigal
J. G. Speciali
机构：
[1] School of Medicine at Ribeirão Preto,The Department of Neurology
[2] The Albert Einstein College of Medicine,Neurology
[3] Hospital das Clínicas de Ribeirão Preto,undefined
来源：
The Journal of Headache and Pain | 2008年 / 9卷
关键词：
Orofacial pain; Burning mouth syndrome; Pramipexol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Burning mouth syndrome (BMS) is characterized by burning discomfort or pain in otherwise normal oral mucosa. It is usually refractory. Treatment modalities are scarce. Herein we report one case of primary disabling BMS, previously refractory to multiple regimens, with complete and persistent improvement with pramipexol, a nonergot dopamine agonist which has high selectivity for dopaminergic D2 receptors. We discuss potential pathophysiological implications of our findings.
引用
收藏
页码：43 / 45
页数：2
相关论文
共 81 条
[1]  
Grushka M(2002)Burning mouth syndrome Am Fam Physician 65 615-620
[2]  
Epstein JB(2006)Burning mouth syndrome Adv Otorhinolaryngol 63 278-287
[3]  
Gorsky M(2002)Orofacial pain: racial and sex differences among older adults J Public Health Dent 62 132-139
[4]  
Grushka M(2002)Sensory dysfunction in burning mouth syndrome Pain 99 41-47
[5]  
Ching V(1993)Sensory and pain thresholds to orofacial argon laser stimulation in patients with chronic burning mouth syndrome Clin J Pain 9 207-215
[6]  
Epstein J(2005)Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome Pain 115 332-337
[7]  
Riley JL(1997)Abnormalities of the blink reflex in burning mouth syndrome Pain 73 445-460
[8]  
Gilbert GH(2003)Striatal dopamine D1 and D2 receptors in burning mouth syndrome Pain 101 149-154
[9]  
Heft MW(2001)Role of the dopaminergic system in chronic pain—a fluorodopa-PET-study Pain 90 257-260
[10]  
Forssell H(2000)Burning mouth syndrome (BMS): controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology Oral Dis 6 274-277
123456789